CWM
BEAM icon

CIBC World Markets’s Beam Therapeutics BEAM Stock Holding History

CIBC World Markets’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$200K Sell
11,781
-8,514
-42% -$148K ﹤0.01% 1288
2025
Q1 		$396K Buy
+20,295
New +$532K ﹤0.01% 1119

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIBC World Markets's BEAM Position: Q2 2025 in Review

CIBC World Markets reduced its Beam Therapeutics (BEAM) stake by 42% in Q2 2025, selling an estimated $148K and leaving 11,781 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

CIBC World Markets first reported a position in BEAM in Q1 2025 and has held it in 2 quarters since. The position peaked at $396K in Q1 2025. 216 funds tracked by Wall St. Rank hold BEAM as of Q2 2025.

  • CIBC World Markets held 11,781 shares of Beam Therapeutics worth $200K as of Q2 2025.
  • CIBC World Markets sold 8,514 Beam Therapeutics shares in Q2 2025, an estimated $148K.
  • Beam Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1288 holding.
  • CIBC World Markets first reported a position in Beam Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Beam Therapeutics position peaked at $396K in Q1 2025.
  • 216 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.